• Citer

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

par Louvet, Christophe;André, Thierry;Lledo, G;Hammel, Pascal;Bleiberg, Harry ;Bouleuc, C;Gamelin, Eric;Flesch, M;Cvitkovic, Esteban;de Gramont, Aimery
Référence Journal of clinical oncology, 20, 6, page (1512-1518)
Publication Publié, 2002-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.
Auteur:	Louvet, Christophe; André, Thierry; Lledo, G; Hammel, Pascal; Bleiberg, Harry; Bouleuc, C; Gamelin, Eric; Flesch, M; Cvitkovic, Esteban; de Gramont, Aimery
Informations sur la publication:	Journal of clinical oncology, 20, 6, page (1512-1518)
Statut de publication:	Publié, 2002-03
Sujet CREF:	Cancérologie
MeSH keywords:	Adenocarcinoma -- drug therapy
	Adult
	Aged
	Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use
	Deoxycytidine -- administration & dosage -- analogs & derivatives
	Dose-Response Relationship, Drug
	Female
	Humans
	Infusions, Intravenous
	Male
	Middle Aged
	Organoplatinum Compounds -- administration & dosage
	Pancreatic Neoplasms -- drug therapy
	Survival Analysis
	Treatment Outcome
Note générale:	Clinical Trial
	Clinical Trial, Phase II
	Journal Article
	Multicenter Study
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.20.6.1512
	info:scp/0037087787
	info:pmid/11896099